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a b s t r a c t 
Retinal tissue receives its supply of oxygen from two sources – the retinal and choroidal circulations. De-
creases in retinal blood ﬂow occur in the early stages of diabetes, with the eventual development of hypoxia
thought to contribute to pathological neovascularization. Oxygen consumption in the retina has been found
to decrease in diabetes, possibly due to either a reduction in neuronal metabolism or to cell death. Diabetes
also enhances the rate of conversion of oxygen to superoxide in the retina, with experimental evidence
suggesting that mitochondrial superoxide not only drives the overall production of reactive oxygen species,
but also initiates several pathways leading to retinopathy, including the increased activity of the polyol and
hexosamine pathways, increased production of advanced glycation end products and expression of their
receptors, and activation of protein kinase C. 
c © 2014 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Oxygen supply to the retina 
The oxygen demand of the retina is high, with the retina among
the most metabolically active tissues in the body. The retina is in
a constant state of activity, converting light into neural signals, and
with the activity continuing (and oxygen consumption even increas-
ing) in the dark. The cells of the retina require a constant supply of
oxygen; however, a dense vascular network anterior to the photore-
ceptors would interfere with light transmission to these light-sensing
cells. To circumvent this potential interference, the outer one-third
to one-half of the retina receives almost all of its oxygen via the
choroidal microcirculation, which is just posterior to the retinal tis-
sue (see Fig. 1 ). The choroidal circulation branches from the posterior
ciliary arteries, which in turn derive from the ophthalmic artery. The
inner one-half to two-thirds of the retina receives its requirement of
oxygen from the retinal circulation, which is a separate branch (via
the central retinal artery) of the ophthalmic circulation. 
The retinal and choroidal circulations differ in their vascular den-
sity, autoregulatory control, and their arterio-venous oxygen differ-
ences, but both circulations are critical for supplying sufﬁcient oxy-
gen to the entire retina. Using microelectrodes, Yu et al. [ 1 , 2 ] have
measured oxygen partial pressures in the retinas of mice and rats,
and have found a very sharp decline from the retinal tissue near the
choroid ( ∼45 mmHg; see Fig. 1 ), with oxygen tension dropping to* Correspondence to: LSUHSC in Shreveport, Department of Molecular & Cellular 
Physiology, 1501 Kings Highway, Shreveport, LA 71130-3932, USA 
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http://dx.doi.org/10.1016/j.redox.2014.04.006 ∼10 to 15 mmHg just anterior to the photoreceptors, consistent with
the high metabolic rate of these neurons. Similar proﬁles have been
obtained for pigs and cats [ 3 ]. The high consumption of oxygen in the
outer retina prevents the choroidal circulation from providing sufﬁ-
cient oxygen to the inner retina in most mammals, excluding rabbits
and guinea pigs. The contribution of the retinal microcirculation to
the oxygenation of the inner retina was demonstrated by Yu et al.
[ 2 ], with experiments in which the retinal circulation of rats was
occluded by laser (retinal ischemia in Fig. 1 ), and measurements of
oxygen tension were close to 0 mmHg throughout the inner retina.
This experimental protocol additionally allowed the researchers to
model the oxygen consumption of the inner retina, since the pres-
ence of ﬂowing vessels in the tissue interferes with such analysis.
Their analysis indicated that oxygen consumption in the inner retina
is substantial, and of the same magnitude as that of the outer retina. 
The choroidal circulation is much more dense than the retinal cir-
culation ( Fig. 1 ), with the sparse nature of the latter important for
light transmission through the retina as mentioned previously. How-
ever, the limited retinal circulation has been speculated to contribute
to the vulnerability of the retina to vascular disease [ 4 ]. 
Utilization of oxygen in the retina 
As mentioned, oxygen proﬁles have helped to identify the sites of
oxygen usage in the retina, with three dominant layers of consump-
tion identiﬁed in the rat as the inner segment of the photoreceptors
(where the mitochondria are localized), the outer plexiform layer
(OPL in Fig. 1 ) and the deeper region of the inner plexiform layer (IPL)
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Fig. 1. Shown to the left in the ﬁgure are the distinct layers of the retina, as seen in a 
hematoxylin–eosin stained cross-section of a mouse. The layers are the ganglion cell 
layer (GCL), the inner plexiform layer (IPL), the inner nuclear layer (INL), the outer 
plexiform layer (OPL), the outer nuclear layer (ONL), and the photoreceptors (PR). The 
retina receives its oxygen from two different circulations, the retinal circulation that 
feeds the inner retina, and the choroidal circulation that feeds the outer retina, with 
cross-sectional depictions of these blood vessels superimposed on the picture at the 
right. Values of retinal oxygen tension are shown in the boxes to the right, with the 
values demonstrating the importance of the retinal circulation to the inner retina as 
described further in the text. 
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  4 ]. Accordingly, these three layers of the retina are also where retinal 
ross-sections stain most intensely for activity of cytochrome oxidase 
 5 ], the enzyme in the ﬁnal step of the mitochondrial respiratory chain 
n which oxygen is consumed in the production of ATP. Much of the 
xygen may be used for synaptic transmission [ 2 ], Na–K ATPase ac- 
ivity, phototransduction [ 6 ], and processes that require substantial 
mounts of energy such as the maintenance of the dark current and 
he generation of guanosine triphosphate [ 3 ]. 
Oxygen consumption increases in the dark, with this increase re- 
ulting in almost complete tissue anoxia in certain areas of the cat 
etina [ 7 ]. However, according to the data of Yu and Cringle [ 8 ], the 
evelopment of anoxia in the dark is not a general property of mam- 
alian retinas, in as much as oxygen tension in the outer retina does 
ot decrease below 5 mmHg in dark-adapted rats, despite an approx- 
mate 50% increase in oxygen consumption. Yu and Cringle explained 
he lack of dark-induced anoxia in the rat retina as being due to a 
igniﬁcant increase in oxygen delivery. In animals in which darkness 
nduces hypoxia, it could be speculated that the hypoxia and / or the 
ubsequent reoxygenation could induce an oxidative stress; however, 
t is not clear whether experimental evidence has supported this pos- 
ibility. 
egulation of retinal blood ﬂow by oxygen 
Oxygen concentrations help regulate retinal blood ﬂow. Not only 
oes hypoxia stimulate increased perfusion and potentially angiogen- 
sis, but the reverse also is true, whereby hyperoxia decreases retinal 
lood ﬂow. The latter phenomenon has been demonstrated by Zhu 
t al. [ 9 ] in experiments in which newborn pigs breathed 100% oxy- 
en, causing retinal blood ﬂow to decrease by ∼40% within 5–10 min. 
his response was attenuated by treatments aimed at several en- 
ogenous vasoconstrictors including thromboxane, endothelin, and 
0-HETE (20-hydroxyeicosatetraeonic acid), but not by the antioxi- 
ant combination of superoxide dismutase and catalase. In compari- 
on, diabetes-induced decreases in retinal blood ﬂow rate in rodents 
decreases of ∼33%) have been found to be attenuated not only by 
argeting thromboxane [ 10 –13 ], endothelin [ 14 ], 20-HETE [ 15 ], and 
ngiotensin II [ 11 ], but also by scavenging superoxide with tempol [ 16 ], with the latter implicating reactive oxygen species (ROS) in reti- 
nal blood ﬂow control during diabetes. Whether or not oxygen levels 
regulate these vasoconstrictor pathways in the diabetic retina has yet 
to be clariﬁed. 
Altered metabolism in the diabetic retina 
Diabetes-induced decreases in retinal oxygen consumption have 
been reported for rabbits [ 17 , 18 ] and cats [ 19 ], but with conﬂicting 
reports of arterio-venous oxygen differences and consumption in the 
diabetic rat retina [ 20 –22 ]. However, Obrosova et al. [ 23 ] have studied 
retinal metabolism in streptozotocin (STZ)-induced diabetes in both 
rats and also mice, at a time point of 6 weeks. They measured several 
metabolites in the retina including pyruvate, lactate, glutamate, α- 
ketoglutarate, ammonia, and free NAD + / NADH. In rats, each of these 
were decreased signiﬁcantly by ∼30% to 50%, but only two of the 
metabolites were decreased in mice (pyruvate by 10%, and ammonia 
by 15%). In humans, arterio-venous oxygen differences have been 
reported to decrease throughout all stages of retinopathy [ 24 ]. In 
as much as early decreases in retinal blood ﬂow have been found 
in diabetic patients [ 25 ], it is likely that oxygen consumption rates 
simultaneously decrease as is the case in several experimental models 
of the disease. Any decrease in retinal oxygen consumption, whether 
transient or sustained, could result in a decrease in retinal blood ﬂow, 
with Small et al. [ 26 ] and Rimmer and Linsenmeier [ 27 ] speculating 
that this mechanism could be operative in the diabetic retina. 
Neuronal cell death may contribute to the decrease in metabolism 
reported in the diabetic retina. STZ-induced diabetes in the rat has 
been found in one study to produce retinal cell death in the time frame 
of 1–12 months [ 28 ], and in another study, the number of apoptotic 
photoreceptors in the STZ rat continued to increase throughout the 
period from 4–24 weeks of hyperglycemia [ 29 ]. The increase in neu- 
ronal cell death in the retina also has been reported in mice injected 
with STZ [ 30 , 31 ], and in the Ins2 Akita diabetic mouse [ 31 ]. Cell death
contributes to the phenomenon of retinal thinning, which is found for 
both rodent [ 30 , 32 ] and human [ 33 –36 ] diabetes. 
Altered oxygen levels in the diabetic retina 
The development of diabetic retinopathy is hypothesized, in part, 
to be a function of retinal hypoxia leading to the uncontrolled growth 
of new retinal blood vessels [ 37 ]. Interestingly, investigators using 
oxygen microelectrodes have found no signs of retinal hypoxia within 
the ﬁrst year of experimentally induced diabetes in cats and dogs [ 38 –
40 ]. Our own lab has studied diabetic mice and rats, and despite ﬁnd- 
ing 20–45% decreases in retinal blood ﬂow rates [ 10 –16 ], we have not 
seen signiﬁcant signs of hypoxia (measured with the probe pimonida- 
zole, and by immunostaining for the hypoxia-inducible factor HIF-1 α) 
early in the progression of hyperglycemia (1–6 months) [ 41 –43 ]. In 
fact, we have detected a possible phase of increased retinal oxygen 
in rats at a time point of 3 months diabetes [ 41 ], with this surpris- 
ing ﬁnding also observed in the inner retina by Lau and Linsenmeier 
[ 44 ] at the same time point, using a more direct measurement with 
oxygen microelectrodes. However, other groups have found signiﬁ- 
cant increases in HIF-1 α and / or pimonidazole staining [ 45 –48 ], and 
therefore, more studies may be required to resolve the time course of 
either hypoxia or hyperoxia early in the progression of experimental 
and human diabetes. 
Even though the most direct measure of retinal oxygen, with 
microelectrodes, has not found hypoxia during the early weeks to 
months in experimental diabetes, Linsenmeier et al. [ 19 ] used this 
technique to reveal signiﬁcant hypoxia at a much longer duration 
(6–7 years of diabetes) in cats, with inner retinal oxygen tension de- 
creased by almost 50% compared to controls. 
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Fig. 2. Hyperglycemia induces superoxide and ROS generation. One pathway of this 
generation includes the mitochondrial electron transport chain, where excessive pro- 
duction of electrons induces their donation to oxygen, creating the superoxide radical. 
Other hyperglycemia-induced pathways leading to ROS (indicated by the dashed line) 
also may contribute to oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Evidence for increased superoxide in experimental diabetic 
retinopathy 
Superoxide can be generated from oxygen by a number of dif-
ferent enzymes, including mitochondrial complex Q, NADPH oxidase,
xanthine oxidase, p450 mono-oxygenase, uncoupled nitric oxide syn-
thase (NOS), cyclooxygenase, and lipoxygenase. The overproduction
of superoxide via one or more of these pathways has been implicated
in the development of diabetic retinopathy. Many reports have been
made of increased retinal superoxide production in rodent models
of diabetic retinopathy. In one of these studies, using the STZ rat
model, retinal superoxide production was found to be increased fol-
lowing 2 months of hyperglycemia, with the increase in superoxide
shown to be produced primarily from the mitochondria, with small
amounts being produced from NADPH oxidase and NOS [ 49 ]. In an STZ
mouse model, superoxide increased in the photoreceptors following
2 months of hyperglycemia: the increase in superoxide occurred in
both light-adapted and dark-adapted diabetic eyes [ 50 ]. 
The activity of the enzyme responsible for converting superox-
ide into oxygen and hydrogen peroxide, superoxide dismutase (SOD),
has been reported to decrease in STZ-induced diabetic rats following
6 weeks [ 51 ], 2 months [ 52 ], and 11 months [ 53 ] of hyperglycemia.
However, it should be mentioned that an increase in SOD activity
(measured as an inhibition of xanthine oxidase) in STZ-induced dia-
betic rats has also been reported [ 54 ]. An increase in SOD would have
the potential of decreasing levels of superoxide due to the conver-
sion to hydrogen peroxide (H 2 O 2 ), which in turn would be efﬁciently
converted to H 2 O in the presence of adequate catalase and / or reac-
tion with glutathione (GSH) in the presence of glutathione peroxidase
(GSH-Px). Catalase has been found to slightly increase in the diabetic
rat retina, with no change in GSH but a decrease in GSH-Px [ 23 ]. 
Role of reactive oxygen species (ROS) in the diabetic retina 
According to the “uniﬁed hypothesis” of diabetes-induced pathol-
ogy [ 55 –57 ], superoxide overproduction is central to the initiation of
parallel deleterious signaling pathways, including the increased ac-
tivity of the polyol and hexosamine pathways, increased production
of advanced glycation end products (AGEs) and expression of their re-
ceptors, and activation of protein kinase C. As shown in Fig. 2 , the over-
production of superoxide due to hyperglycemia could involve the mi-
tochondrial electron transport chain, due to the increased metabolism
of glucose generating pyruvate that enters Kreb ’ s cycle. The electron
donors (NADH, FADH 2 ) that are produced enter the mitochondrial
electron transport chain, resulting in the extrusion of protons and the
crossing of a critical threshold of mitochondrial membrane voltage.
Once this threshold is exceeded, electron transfer (in complex III) is
blocked, causing coenzyme Q to donate electrons to O 2 , generating
superoxide. Additional reactive oxidants are formed when superox-
ide dismutase converts O 2 
− to hydrogen peroxide (H 2 O 2 ), which can
be reduced to the highly reactive hydroxide anion (OH −). Superox-
ide also can react with nitric oxide to form the highly reactive (and
protein modifying) anion peroxynitrite (ONOO −). 
Evidence for the role of mitochondrial superoxide as the initial
reactive oxidant produced by hyperglycemia has been demonstrated
with in vitro experiments in which the mitochondrial voltage gradi-
ent was collapsed by overexpressing the uncoupling protein (UCP-1)
that helps regulate the production of superoxide. This manipulation,
and also overexpressing MnSOD (found almost exclusively in the mi-
tochondria) were both able to prevent hyperglycemia-induced pro-
duction of ROS in vitro [ 58 ]. Overexpression of MnSOD also has been
performed in vivo, in diabetic mice, with the retinas protected from
oxidative damage to proteins and DNA [ 59 ]. 
Although the mitochondria may be the initial producer of super-
oxide due to hyperglycemia, this process in turn may activate other
superoxide-generating pathways in diabetic tissue such as redoxchanges, uncoupled NOS, and NADPH oxidase [ 56 ]. The potential im-
portance of NADPH oxidase (speciﬁcally, NOX2) was found in exper-
iments in which blocking the effects of the enzyme was able to com-
pletely eliminate the diabetes-induced increase in ROS production, as
measured by dichloroﬂuorescein (DCF) intensity in cross-sections of
the diabetic mouse retina [ 60 ]. In these experiments, DCF intensity
was no greater than controls in either NOX2-deﬁcient mice or in mice
treated with the NOX inhibitor apocynin. This may appear to differ
from the ﬁndings of Nishikawa et al. [ 58 ], who found evidence that
mitochondrial superoxide is responsible for hyperglycemia-induced
increases in ROS generation. However, a link between these two
mechanisms could exist, as suggested by Al-Shabrawey et al. [ 60 ],
who proposed that mitochondria-derived ROS may trigger protein
kinase C to activate NOX, and with other studies [ 61 −63 ] providing
evidence that NOX can sustain the ROS formation initiated by the
mitochondria. 
The evidence for increased retinal oxidative stress in the diabetic
retina has prompted experimental studies of antioxidant therapies
in animal models of diabetic retinopathy. As reviewed by Madsen-
Bouterse and Kowluru [ 64 ], administration of lipoic acid to rats pro-
tects retinal capillary cells from apoptosis and attenuates retinal mi-
tochondrial dysfunction [ 53 , 55 ]. Vitamins C and E given to diabetic
rats decrease the number of acellular capillaries (that is, lost peri-
cytes and endothelial cells) in the retinal microvasculature [ 65 ], with
the number of acellular capillaries also decreased by overexpression
of MnSOD in diabetic mice, which reduces oxidative stress [ 66 ]. The
same beneﬁts in diabetic rats are seen via administration of green tea
extract [ 67 ] and other nutritional supplements [ 68 ]. Whether these
treatments will be effective in human diabetic retinopathy have yet to
be determined: diet recall in diabetic patients has not demonstrated
any strong evidence for protection by the antioxidants ascorbic acid,
α-tocopherol, and vitamins C and E [ 69 , 70 ], but a comprehensive
literature review of the effects of vitamin C and SOD on human di-
abetic retinopathy indicates that no research to date has adequately
addressed the potential for clinical beneﬁts [ 71 ]. 
Connection between mitochondrial superoxide and parallel 
pathways of damage 
Diabetes causes a decrease in the activity of the glycolytic en-
zyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and with
this decrease, glycolytic intermediates upstream of GAPDH increase,
which increases ﬂux into the parallel pathways mentioned earlier,
that is, the polyol and hexosamine pathways, production of advanced
glycation end products (AGEs) and expression of their receptors,
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Fig. 3. Hyperglycemia-induced ROS production increases levels of poly(ADP-ribose) 
polymerase (PARP), which inhibits glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) activity. The consequences of inhibited GAPDH include an increase in methyl- 
glyoxal, increased activity of the polyol and hexosamine pathways, increased produc- 
tion of advanced glycation end products (AGEs) and expression of their receptors, 
and activation of protein kinase C (PKC). The effects on HIF-1 αmay be mixed, being 
stimulated by ROS but inhibited by methylglyoxal. 
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y hyperglycemia in vivo in a mechanism whereby superoxide in- 
reases levels of poly(ADP-ribose) polymerase (PARP) [ 72 ]. The re- 
ulting polymers of ADP-ribose accumulate on GAPDH, rendering it 
nactive. However, this inhibition of GAPDH activity does not occur 
n hyperglycemia when mitochondrial production of superoxide is 
nhibited [ 73 ]. 
egulation of hypoxia inducible factors by ROS 
Neovascularization is a characteristic of the later stages of dia- 
etic retinopathy [ 74 , 75 ]. It is thought that the stabilization and ac- 
ivation of hypoxia inducible factor 1 α (HIF-1 α) contributes to the 
pregulation of angiogenic factors leading to the neovascularization 
 76 ]. Kietzmann and G ¨orlach [ 77 ] have reviewed potential mecha- 
isms by which ROS may regulate the expression of HIF-1 α, including 
ia prolyl hydroxylase, extracellular-signal-regulated kinase (ERK), 
38 mitogen-activated protein kinase, and protein kinase B, with the 
ource of ROS in these mechanisms likely to include those derived by 
he mitochondria and by NADPH oxidase [ 78 ]. ROS-dependent regu- 
ation of HIF-1 α does not always correlate with the level of hypoxia, 
nd interestingly, hyperoxia can stimulate the mitochondrial produc- 
ion of ROS in endothelial cells, leading to activation of NADPH oxi- 
ase [ 79 ]. Other studies as well have documented the production of 
OS due to hyperoxia [ 80 −83 ]. However, whether ROS generated by 
yperoxia contributes to oxygen-dependent vasoconstriction in the 
etina is questionable, given the previously mentioned study by Zhu 
t al. [ 9 ] in which SOD / catalase was unable to attenuate hyperoxia- 
nduced decreases in retinal blood ﬂow. 
Although ROS have been shown to stabilize and activate HIF-1 α, 
yperglycemia has been shown to downregulate HIF-1 α [ 84 ], and 
he mechanism of downregulation appears to be in part due to bind- 
ng of HIF-1 α by methylglyoxal [ 85 , 86 ], a byproduct of glycolysis. 
he methylglyoxal-induced downregulation of HIF-1 α has been im- 
licated as preventing ischemia-induced vasculogenesis in diabetes 
 86 ]; which also could possibly contribute to the presence of ischemic regions in the diabetic retina. However, one or more aspects of this 
mechanism may be altered or bypassed in certain areas of the retina 
in the later stages of diabetic retinopathy, given the deleterious an- 
giogenesis that occurs. Further investigation into the mechanisms of 
HIF-1 α stabilization and activation, and the clinical implications of 
these results is warranted. Fig. 3 summarizes some of the pathways 
initiated by retinal production of superoxide in diabetes, incorporat- 
ing the pathways involving PARP-induced decreases in GAPDH, and 
methylglyoxal- and ROS-mediated changes in HIF-1 α. 
Summary 
Diabetic retinopathy involves alterations in oxygen delivery, oxy- 
gen consumption, and superoxide production, with the interdepen- 
dence of these mechanisms still yet to be determined. Reports of 
increased retinal oxidative stress in the diabetic retina have led to 
experimental studies of antioxidant therapies, which have shown 
promise in animal models of diabetic retinopathy. Such treatments 
have included agents such as lipoic acid, vitamins C and E, MnSOD, 
green tea extract, and nutritional antioxidant supplements [ 64 ]. To 
date, less is known concerning the potential long-term effects of tar- 
geting diabetes-induced changes in blood ﬂow and oxygen delivery. 
The degree to which therapies directed at oxygen delivery, usage, and 
production of superoxide will attenuate human diabetic retinopathy 
awaits further investigation. 
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